EB-1B Green Card for Boston's Outstanding Researchers
EB-1B is the fastest employer-sponsored green card for researchers and scientists. Boston's academic medical centers, universities, and biotech companies use it regularly because it requires no PERM labor certification.
EB-1B requires a permanent job offer — the employer must intend to employ the researcher permanently — but it skips PERM entirely. For Harvard-affiliated hospitals, MIT, and the Broad Institute, this is the preferred route for research scientists and faculty who have a permanent track available. Eliminating the 3–4 year PERM process alone makes EB-1B dramatically more efficient than the standard EB-2 pathway.
Standard EB-1B processing takes approximately 6–12 months for the I-140; premium processing (Form I-907) brings that to 15 business days. Boston institutions' immigration offices are well-versed in the standard. Harvard, MIT, and the Dana-Farber/HMS network process dozens of EB-1B petitions per year, and institutional immigration counsel at these organizations typically know exactly what the Vermont Service Center expects.
For researchers on O-1A status whose institutions are ready to offer a permanent position, EB-1B is often the cleanest green card path. The same publication record and institutional recognition that supported the O-1A petition typically satisfies EB-1B criteria with minimal additional work. And because the EB-1 category priority dates are current for most nationalities, there is little to no queue after the I-140 is approved.
Key institutions
Where Boston EB-1B petitions originate.
These are the institutions that most frequently sponsor EB-1B for their research faculty and scientists. Each has distinct policies around what roles qualify as permanent for EB-1B purposes.
MIT & Harvard University
Sponsor EB-1B for research scientists, senior postdocs on permanent tracks, and faculty; institutional immigration offices are experienced with the outstanding researcher standard.
Broad Institute of MIT & Harvard
Staff scientists with strong publication records; EB-1B filed when the institute will employ the researcher permanently. Authorized agent filing is not available for EB-1B — employer sponsorship is required.
Dana-Farber / Mass General / BWH
HMS-affiliated hospitals sponsor EB-1B for instructors, clinical research fellows, and research scientists on permanent tracks; high-volume oncology and clinical research output supports the record.
Kendall Square biotech corridor
Biogen, Vertex, Moderna and other corridor companies sponsor EB-1B for senior and principal scientists with permanent research roles; patent and salary evidence typically bolsters the academic record.
Whitehead Institute & Koch Institute
MIT-affiliated; EB-1B filed for research scientists on non-postdoc permanent tracks; publication records are typically strong and peer recognition well-documented.
Harvard Chan & Northeastern
Public health and engineering faculty and research scientists; EB-1B is used when the institution offers a permanent research position with clear organizational importance.
Eligibility
EB-1B criteria for Boston researchers.
EB-1B requires international recognition as outstanding in the field, plus a permanent job offer and employer sponsorship. These four criteria come up most often for Boston research profiles:
01
International recognition — prizes, awards, and fellowships
USCIS looks for prizes, awards, fellowships, or significant recognition from peers and institutions in the field. NIH career awards (K99/R00, K08), named lectureships, and editorial board positions all count. The recognition need not be a single prestigious prize; a consistent pattern of peer-recognized achievement across the career record satisfies the standard.
02
Scholarly articles in peer-reviewed journals
Publication record in major journals is the core evidence. USCIS looks at quality (journal impact factor and prestige), authorship position (first-author and corresponding-author carry the most weight), and total volume. Most Boston researchers at the target career stage — research scientist and above — have records that clearly satisfy this criterion.
03
Critical or leading role in a distinguished organization
PI of an active research program, lab head, or senior scientist with documented organizational importance. The institution itself must qualify as distinguished — MIT, Harvard, and the major Boston hospitals easily meet this bar. The petition letter from the department head documenting the researcher's specific critical role is often the most important piece of evidence here.
04
Other contributions of major significance
Judging grant applications or manuscripts, organizing major conferences, patent filings, and supervisory roles training PhD students or postdocs are all documented contributions that strengthen EB-1B petitions. Industry scientists can supplement with patent portfolios and press coverage. Each contribution should be framed in terms of its impact on the field or the organization.
Boston EB-1B profiles
What qualifying EB-1B records look like.
Representative profiles from Boston-area EB-1B I-140 petitions. Identifying details have been generalized.
Assistant Professor
Harvard Medical School
Cancer immunology, tumor microenvironment
34 publications; 4 first-author papers in Cancer Cell and Journal of Clinical Investigation
K99/R00 awardee; NIH R21 as PI; peer reviewer for JCI, Cancer Research, and JAMA Oncology
Invited speaker at AACR and ASH Annual Meetings
Named lecturer at two international cancer symposia
Editorial board member, Cancer Immunology Research
Sponsored by HMS; PERM bypassed entirely. Concurrent self-petitioned EB-1A I-140 filed in parallel.
Research Scientist II
MIT Department of Biology
Structural biology, protein folding mechanisms
28 peer-reviewed publications; 3 patents on cryo-EM sample preparation
Ad hoc reviewer for Nature Structural & Molecular Biology and eLife
Co-organizer of Cold Spring Harbor protein folding workshop
Invited seminar at Rockefeller University and Yale School of Medicine
Supervisor of 4 PhD student research rotations in the lab
Sponsored by the department. Permanent research scientist track; no faculty appointment required for EB-1B.
Salary in top 15% of field per BLS and industry survey data
Critical role leading the vector biology group (10-person team)
Company press coverage in STAT News and Fierce Biotech
Invited speaker at ASGCT Annual Meeting
Sponsored by employer. Industry EB-1B petitions emphasize critical role, patent record, and salary relative to field peers.
Comparing paths
EB-1B vs. EB-1A for Boston researchers.
The key distinction: EB-1B requires a permanent job offer and an employer sponsor; EB-1A is entirely self-petitioned. EB-1B carries a slightly lower evidentiary bar — the standard is "outstanding" rather than "extraordinary" ability — making it more accessible at an earlier career stage. But the employer dependency is a meaningful constraint: if your institution won't commit to a permanent role, EB-1B is unavailable regardless of how strong the research record is.
Both EB-1B and EB-1A skip PERM entirely. Many Boston researchers file employer-sponsored EB-1B and self-petition EB-1A simultaneously — two parallel green card paths, no PERM on either, using largely the same evidence package. This parallel strategy is common at HMS, MIT, and the Broad: the institution files EB-1B, and the researcher independently files EB-1A at the same time. If EB-1A is approved first, that path wins; if EB-1B clears first, same outcome.
For researchers whose institutions won't sponsor at all, the alternatives are EB-1A self-petition and EB-2 NIW — both of which require no employer. See the EB-1B vs. NIW comparison and the full EB-1B overview.
FAQ
Boston EB-1B questions.
Yes. EB-1B requires a permanent job offer from a US employer and the employer must file the I-140. Unlike EB-1A, which is self-petitioned, there is no authorized agent option for EB-1B. If your current institution won't sponsor you — which is more common than many researchers expect, particularly for postdocs whose positions are not permanently classified — you have two options: negotiate a permanent research scientist appointment that enables sponsorship, or pursue EB-1A self-petition (which is available without employer action) or EB-2 NIW as parallel paths.
EB-1B requires a permanent job offer and employer sponsorship; EB-1A is self-petitioned with no employer required. EB-1B's evidentiary bar is slightly lower — outstanding rather than extraordinary ability — which makes it accessible to a somewhat earlier-career research profile. In practice, many Boston researchers who qualify for EB-1B also qualify for EB-1A; when that's the case, filing both is often the right strategy. EB-1B through your institution, EB-1A on a parallel self-petition track.
No. EB-1B explicitly waives the PERM requirement. This is one of its primary advantages over EB-2 PERM-based filings, which can take 3–4 years before the I-140 can even be filed. For Boston research institutions that have a permanent role available, EB-1B is almost always faster than the standard EB-2 track.
Institutional immigration offices sometimes decline to file EB-1B for postdocs, instructors, or junior researchers, either because they categorize the role as temporary or because they lack bandwidth. In that case, outside immigration counsel (like USIA) can work directly with the research department to structure the petition. The department head's support is key: they sign the letter confirming the permanent nature of the position and the researcher's critical role. We can draft the petition while coordinating directly with the department.
Priority dates for EB-1B (EB-1 category) have historically been current or close to current for most countries, meaning there is little to no wait after I-140 approval to file for adjustment of status or consular processing. Processing time for the I-140 itself is approximately 6–12 months under standard processing; premium processing (Form I-907) brings it to 15 business days. Once the I-140 is approved and a visa number is available, adjustment of status adds another 12–24 months in the US, or consular processing takes 6–12 months from NVC to visa issuance.
